ARCHIVES

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

This article is from The Cancer Letter archive.

Vol. 12 No. 47 | December 5, 1986

Download PDF Visit The Full Archive

Related Articles

Immune System Booster Shown Safe For Prostate Cancer; Fewer Side Effects

August 29, 2008

NCI Advisory Group, other Cancer Meetings

July 29, 1988

Smoking Cessation Training Follows Doctors Into Practice

October 29, 2004

In Brief: Pelayo Correa Heads LSU Cancer Center; Foundation to Honor Feinstein, Mack

September 5, 1997

In Brief: Four To Share In $100,000 Hammer Prize; Oldham To Head New Genetic Engineering Firm In Texas

February 3, 1984

ONS Opposes AMA On “Registered Care Technologist”

August 19, 1988